Patient-Reported Outcome Consortium
The Patient-Reported Outcome Consortium supports patient-focused drug development by obtaining qualification of clinical outcome assessment tools that measure how patients feel and function in their everyday lives as a result of treatment.
News
-
Dec 16, 2022 eCOA Consortium and PRO Consortium Announce Publication of Two Open Access Articles -
Sep 27, 2022 Global Biopharmaceutical Leader to Usher C-Path in Next Phase of Growth and Innovation -
Sep 8, 2022 C-Path’s Kristen Swingle Named President
-
Aug 5, 2022 PRO Consortium Announces Publication of Open Access Article
Publications
-
Dec 16, 2022 Quantitative Study Findings: Comparability of a Provisioned Device Versus Bring Your Own Device… -
Dec 16, 2022 Qualitative Interview Findings: Comparability of a Provisioned Device Versus Bring Your Own Device…
-
Jul 19, 2022 Comparing patient global impression of severity and patient global impression of change to evaluate test–retest reliability of depression, non-small cell lung cancer, and asthma measures
-
Jun 8, 2022 Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): measurement properties and estimated clinically meaningful thresholds from a phase 3 study
-
May 16, 2022 Recommendations for the Electronic Migration and Implementation of Clinician-Reported Outcome Assessments in Clinical Trials